These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 177990)

  • 1. Epiphyseal cartilage cyclic nucleotide phosphodiesterase: partial purification and kinetic characteristics of multiple enzymes.
    Ishikawa Y; Newcombe DS
    Proc Soc Exp Biol Med; 1976 May; 152(1):105-10. PubMed ID: 177990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
    Lavan BE; Lakey T; Houslay MD
    Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic nucleotide phosphodiesterases from rat anterior pituitary. Characterization of multiple forms and regulation by protein activator and Ca+.
    Azhar S; Menon KM
    Eur J Biochem; 1977 Feb; 73(1):73-82. PubMed ID: 190011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal medullary cyclic nucleotide phosphodiesterase. Subcellular distribution, partial purification and regulation of enzyme activity.
    Egrie JC; Siegel FL
    Biochim Biophys Acta; 1977 Aug; 483(2):348-66. PubMed ID: 196651
    [No Abstract]   [Full Text] [Related]  

  • 6. Heat-stable low molecular weight form of phosphodiesterases from bovine pineal gland.
    Sankaran K; Hanbauer I; Lovenberg W
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3188-91. PubMed ID: 210451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
    Price B; Pyne NJ; Houslay MD
    Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic and regulatory properties of two forms of bovine heart cyclic nucleotide phosphodiesterase.
    Ho C; Teo TS; Desai R; Wang JH
    Biochim Biophys Acta; 1976 Apr; 429(2):461-73. PubMed ID: 177071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity.
    Nagasaka A; Hidaka H
    Biochim Biophys Acta; 1976 Jul; 438(2):449-60. PubMed ID: 182233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic 3',5'-nucleotide phosphodiesterase in rat skin. II. Biochemical characterization.
    King LE; Solomon SS; Hasimoto K
    J Invest Dermatol; 1975 Jun; 64(6):390-6. PubMed ID: 237964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
    Hidaka H; Asano T
    Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
    Souness JE; Diocee BK; Martin W; Moodie SA
    Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-dependent cyclic nucleotide phosphodiesterase from brain: comparison of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate as substrates.
    Brostrom CO; Wolff DJ
    Arch Biochem Biophys; 1976 Jan; 172(1):301-11. PubMed ID: 175742
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for the activity of five adenosine-3',5'-monophosphate-degrading phosphodiesterase isozymes in the adult rat neocortex.
    Sutor B; Mantell K; Bacher B
    Neurosci Lett; 1998 Aug; 252(1):57-60. PubMed ID: 9756358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of imidazole on the hydrolysis of cyclic AMP and cyclic GMP by bovine heart and rat liver cyclic nucleotide phosphodiesterases.
    Donnelly TE
    Arch Biochem Biophys; 1976 Mar; 173(1):375-85. PubMed ID: 4034
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
    Lugnier C; Schini VB
    Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3':5'-cyclic-nucleotide phosphodiesterases of mammalian sera.
    Asano T; Hidaka H
    Biochim Biophys Acta; 1975 Jul; 397(1):124-33. PubMed ID: 238629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher-plant cyclic nucleotide phosphodiesterases. Resolution, partial purification and properties of three phosphodiesterases from potato tuber.
    Ashton AR; Polya GM
    Biochem J; 1975 Aug; 149(2):329-39. PubMed ID: 241333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
    Weishaar RE; Quade MM; Schenden JA; Evans DB
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.